Your Article Summary
Population Pharmacokinetics of Acyclovir in Children and Young People with Malignancy after Administration of Intravenous Acyclovir or Oral Valacyclovir
Antimicrobial Agents and Chemotherapy, 06/30/09
Zeng L et al. - Acyclovir is effective in the prevention and treatment of herpes simplex virus and varicella-zoster virus infections. This validated population pharmacokinetic model for acyclovir may be used to develop dosing guidelines for safe and effective antiviral therapy in young people with malignancy.
Related Articles
Long-Term Administration of Valacyclovir Reduces the Number of Epstein-Barr Virus (EBV)-Infected B Cells but Not the Number of EBV DNA Copies per B Cell in Healthy Volunteers ,
Journal of Virology, 11/09/09
Relevance Score: 84%
Do Either Corticosteroids or Antiviral Agents Reduce the Risk of Long-Term Facial Paresis in Patients with New-onset Bells Palsy
The Journal of Emergency Medicine, 10/23/09
Relevance Score: 80%
Incidence, Risk Factors, and Severity of Herpesvirus Infections in a Cohort of 121 Patients With Primary Dermatomyositis and Dermatomyositis Associated With a Malignant Neoplasm
Internet Source, 10/05/09
Relevance Score: 80%
Newer trends in the management of genital herpes
Indian Journal of Dermatology, Venereology and Leprology, 11/18/09
Relevance Score: 77%
Today in Peds Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of mefloquine and artesunate mefloquine on the emergence, clearance and sex ratio of Plasmodium falciparum gametocytes in malarious children
Malaria Journal, 12/17/09
Changing Incidence of Methicillin-Resistant Staphylococcus aureus Skin Abscesses in a Pediatric Emergency Department
Pediatric Emergency Care, 12/17/09
Between adversity and agency: Child and youth-headed households in Namibia *TEST*
Vulnerable Children and Youth Studies, 12/17/09

See Latest Articles